Metformin Oresund Pharma

Metformin Hydrochloride, the active ingredient in Metformin Oresund Pharma, is a biguanide presented as an oral tablet for systemic use. It is indicated for the management of type 2 diabetes mellitus in adult patients, helping to improve glycaemic control when used as part of a comprehensive diabetes treatment plan that includes diet and exercise.

GNH USA supplies Metformin Oresund Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring product quality and regulatory compliance across EU and global markets.

Metformin Hydrochloride is used to treat disorders of glucose metabolism, primarily type 2 diabetes mellitus.

- Type 2 diabetes mellitus: improves glycaemic control as part of diet and exercise regimen. - Impaired glucose tolerance (prediabetes): delays progression to overt diabetes when combined with lifestyle modification. - Metabolic syndrome: assists in managing insulin resistance and associated dyslipidaemia.

Metformin Hydrochloride may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: transient gastrointestinal upset, often resolves with continued therapy. - Diarrhoea: loose stools that may improve over time. - Abdominal discomfort: cramping or bloating, usually mild. - Metallic taste: temporary alteration in taste perception.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening metabolic complication. - Vitamin B12 deficiency: may develop with long‑term use, requiring monitoring. - Severe hypoglycaemia: typically when combined with insulin or secretagogues.

When prescribing Metformin Hydrochloride, several safety considerations should be observed.

- Renal function: assess creatinine clearance before initiation and periodically. - Hepatic function: evaluate liver disease risk as impaired function increases lactic acidosis. - Lactic acidosis risk: avoid in patients with hypoxia, heart failure, or severe infection. - Elderly patients: start at lower dose and monitor tolerance. - Concomitant medications: review drugs that may affect renal clearance or increase acidosis risk. - Store at room temperature: keep in original container, protect from moisture and heat.

Metformin Hydrochloride interacts with several medicines; some require avoidance while others need careful monitoring.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and lactic acidosis. - Cimetidine: can increase metformin plasma concentrations. - Alcohol: excessive intake raises risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - ACE inhibitors or ARBs: can affect renal function, monitor creatinine. - Thiazide diuretics: may increase risk of hypoglycaemia, monitor glucose.